Thalys Medical Technology Group Inc banner

Thalys Medical Technology Group Inc
SSE:603716

Watchlist Manager
Thalys Medical Technology Group Inc Logo
Thalys Medical Technology Group Inc
SSE:603716
Watchlist
Price: 24.68 CNY 0.08% Market Closed
Market Cap: ¥5.2B

Thalys Medical Technology Group Inc
Investor Relations

Thalys Medical Technology Group, Inc. engages in the research, development, production, and sale of in vitro diagnostic products. The company is headquartered in Wuhan, Hubei and currently employs 1,637 full-time employees. The company went IPO on 2016-10-31. Its product type includes purchased reagents and consumables, self-produced reagents and consumables, as well as purchased equipment. The firm mainly operates its business in domestic markets, with Hubei, Hunan, Jiangsu, Henan and Shanghai province as its major markets.

Show more
Loading
603716
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Zheng Wang
GM & Director
No Bio Available
Ms. Yan Shen
Chief Financial Officer
No Bio Available
Ms. Li Fan
Deputy GM, Acting Secretary of the Board & Director
No Bio Available
Mr. Xiao Ming Wen
Director of GM Office & Director
No Bio Available
Ms. Feng Cai
Board Secretary
No Bio Available
Mr. Yi Lu
Deputy General Manager
No Bio Available
Mr. Jun Sun
Administrative Director
No Bio Available
Mr. Feng Liu
GM of SPD Business & Regional Inspection Center Business Department and Deputy GM
No Bio Available

Contacts

Address
HUBEI
Wuhan
No.1310 Jinshan Avenue, Dongxi Lake District
Contacts
+862783386378
www.thalys.net.cn
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett